COMPLICAÇÕES DA NEURITE ÓPTICA EM PACIENTES IMUNOSSUPRIMIDOS Article Swipe
Pedro Pereira da Silva Neto
,
Leandra Amarante Rodrigues Ferreira
,
Fernanda Alkmim Rezende Teixeira
,
Willimar Gleiser Schmidt Binsfeld
,
Mayara da Costa Rodrigues
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.51891/rease.v10i12.17416
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.51891/rease.v10i12.17416
Introdução: A neurite óptica é uma inflamação do nervo óptico que pode resultar em perda de visão, sendo frequentemente associada a doenças autoimunes, como a esclerose múltipla. Em pacientes imunossuprimidos, devido ao uso de medicamentos ou doenças subjacentes, as complicações da neurite óptica podem ser mais intensas e difíceis de tratar. A imunossupressão pode alterar a resposta inflamatória do organismo, tornando o diagnóstico e tratamento mais desafiadores. Objetivo: Analisar as complicações da neurite óptica em pacientes imunossuprimidos, focando nos fatores que podem agravar o quadro clínico e as implicações para o tratamento e prognóstico desses pacientes. Metodologia: A revisão foi realizada com base nas diretrizes do checklist PRISMA. Foram realizadas buscas nas bases de dados PubMed, Scielo e Web of Science, utilizando os seguintes descritores: "neurite óptica", "pacientes imunossuprimidos", "tratamento", "complicações" e "perda visual". A seleção dos artigos se concentrou em estudos publicados nos últimos 10 anos, com foco em revisões sistemáticas, estudos clínicos e pesquisas experimentais relevantes.Critérios de Inclusão: Foram incluídos estudos clínicos e revisões sistemáticas sobre complicações da neurite óptica em pacientes imunossuprimidos, publicados nos últimos 10 anos, com foco em diagnóstico e tratamento. Foram excluídos estudos que não abordavam a população imunossuprimida ou que tratavam de doenças não relacionadas à neurite óptica. Resultados: Os resultados indicaram que a neurite óptica em pacientes imunossuprimidos apresenta maior risco de complicações, como progressão acelerada da perda de visão, além de dificuldades no tratamento devido ao uso de medicamentos imunossupressores. Muitos estudos destacaram a importância de um diagnóstico precoce e o controle rigoroso da imunossupressão para minimizar o impacto visual. Além disso, o prognóstico é variável, dependendo da gravidade da inflamação e da resposta ao tratamento. Conclusão: Em pacientes imunossuprimidos, a neurite óptica está frequentemente associada a complicações que dificultam tanto o diagnóstico quanto o tratamento adequado. O controle da imunossupressão e o acompanhamento especializado são essenciais para evitar sequelas permanentes e promover um melhor prognóstico visual. A literatura sugere que abordagens terapêuticas mais agressivas podem ser necessárias nesses casos, sempre com a consideração dos riscos inerentes ao estado imunossuprimido.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- pt
- Landing Page
- https://doi.org/10.51891/rease.v10i12.17416
- https://periodicorease.pro.br/rease/article/download/17416/9780
- OA Status
- diamond
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4405058770
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4405058770Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.51891/rease.v10i12.17416Digital Object Identifier
- Title
-
COMPLICAÇÕES DA NEURITE ÓPTICA EM PACIENTES IMUNOSSUPRIMIDOSWork title
- Type
-
articleOpenAlex work type
- Language
-
ptPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-12-05Full publication date if available
- Authors
-
Pedro Pereira da Silva Neto, Leandra Amarante Rodrigues Ferreira, Fernanda Alkmim Rezende Teixeira, Willimar Gleiser Schmidt Binsfeld, Mayara da Costa RodriguesList of authors in order
- Landing page
-
https://doi.org/10.51891/rease.v10i12.17416Publisher landing page
- PDF URL
-
https://periodicorease.pro.br/rease/article/download/17416/9780Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
diamondOpen access status per OpenAlex
- OA URL
-
https://periodicorease.pro.br/rease/article/download/17416/9780Direct OA link when available
- Concepts
-
Medicine, Neurite, Gynecology, In vitro, Biology, BiochemistryTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4405058770 |
|---|---|
| doi | https://doi.org/10.51891/rease.v10i12.17416 |
| ids.doi | https://doi.org/10.51891/rease.v10i12.17416 |
| ids.openalex | https://openalex.org/W4405058770 |
| fwci | 0.0 |
| type | article |
| title | COMPLICAÇÕES DA NEURITE ÓPTICA EM PACIENTES IMUNOSSUPRIMIDOS |
| biblio.issue | 12 |
| biblio.volume | 10 |
| biblio.last_page | 1170 |
| biblio.first_page | 1159 |
| topics[0].id | https://openalex.org/T12599 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9710999727249146 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2731 |
| topics[0].subfield.display_name | Ophthalmology |
| topics[0].display_name | Retinal and Optic Conditions |
| topics[1].id | https://openalex.org/T11194 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9093999862670898 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2731 |
| topics[1].subfield.display_name | Ophthalmology |
| topics[1].display_name | Ocular Diseases and Behçet’s Syndrome |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.7887891530990601 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C113246987 |
| concepts[1].level | 3 |
| concepts[1].score | 0.7278655767440796 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1534415 |
| concepts[1].display_name | Neurite |
| concepts[2].id | https://openalex.org/C29456083 |
| concepts[2].level | 1 |
| concepts[2].score | 0.4145638942718506 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1221899 |
| concepts[2].display_name | Gynecology |
| concepts[3].id | https://openalex.org/C202751555 |
| concepts[3].level | 2 |
| concepts[3].score | 0.11050951480865479 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q221681 |
| concepts[3].display_name | In vitro |
| concepts[4].id | https://openalex.org/C86803240 |
| concepts[4].level | 0 |
| concepts[4].score | 0.05351364612579346 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[4].display_name | Biology |
| concepts[5].id | https://openalex.org/C55493867 |
| concepts[5].level | 1 |
| concepts[5].score | 0.0 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[5].display_name | Biochemistry |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.7887891530990601 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/neurite |
| keywords[1].score | 0.7278655767440796 |
| keywords[1].display_name | Neurite |
| keywords[2].id | https://openalex.org/keywords/gynecology |
| keywords[2].score | 0.4145638942718506 |
| keywords[2].display_name | Gynecology |
| keywords[3].id | https://openalex.org/keywords/in-vitro |
| keywords[3].score | 0.11050951480865479 |
| keywords[3].display_name | In vitro |
| keywords[4].id | https://openalex.org/keywords/biology |
| keywords[4].score | 0.05351364612579346 |
| keywords[4].display_name | Biology |
| language | pt |
| locations[0].id | doi:10.51891/rease.v10i12.17416 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210238184 |
| locations[0].source.issn | 2675-3375 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2675-3375 |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Revista Ibero-Americana de Humanidades, Ciências e Educação |
| locations[0].source.host_organization | https://openalex.org/P4365394759 |
| locations[0].source.host_organization_name | Arche Scientific and Editorial Consultancy |
| locations[0].source.host_organization_lineage | https://openalex.org/P4365394759 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://periodicorease.pro.br/rease/article/download/17416/9780 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Revista Ibero-Americana de Humanidades, Ciências e Educação |
| locations[0].landing_page_url | https://doi.org/10.51891/rease.v10i12.17416 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5102699477 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Pedro Pereira da Silva Neto |
| authorships[0].countries | BR |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210106570 |
| authorships[0].affiliations[0].raw_affiliation_string | Universidade Federal do Triângulo Mineiro |
| authorships[0].institutions[0].id | https://openalex.org/I4210106570 |
| authorships[0].institutions[0].ror | https://ror.org/01av3m334 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210106570 |
| authorships[0].institutions[0].country_code | BR |
| authorships[0].institutions[0].display_name | Universidade Federal do Triângulo Mineiro |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Pedro Pereira da Silva Neto |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Universidade Federal do Triângulo Mineiro |
| authorships[1].author.id | https://openalex.org/A5070338922 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Leandra Amarante Rodrigues Ferreira |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Leandra Amarante Rodrigues Ferreira |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5101353261 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Fernanda Alkmim Rezende Teixeira |
| authorships[2].countries | BR |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210107309 |
| authorships[2].affiliations[0].raw_affiliation_string | FCMMG |
| authorships[2].institutions[0].id | https://openalex.org/I4210107309 |
| authorships[2].institutions[0].ror | https://ror.org/01p7p3890 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210107309 |
| authorships[2].institutions[0].country_code | BR |
| authorships[2].institutions[0].display_name | Faculdade de Ciências Médicas de Minas Gerais |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Fernanda Alkmim Rezende Teixeira |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | FCMMG |
| authorships[3].author.id | https://openalex.org/A5093332555 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Willimar Gleiser Schmidt Binsfeld |
| authorships[3].countries | BR |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I3123346794 |
| authorships[3].affiliations[0].raw_affiliation_string | Universidade Estadual do Piauí |
| authorships[3].institutions[0].id | https://openalex.org/I3123346794 |
| authorships[3].institutions[0].ror | https://ror.org/02na6tz09 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I3123346794 |
| authorships[3].institutions[0].country_code | BR |
| authorships[3].institutions[0].display_name | Universidade Estadual do Piauí |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Willimar Gleiser Schmidt Binsfeld |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Universidade Estadual do Piauí |
| authorships[4].author.id | https://openalex.org/A5034910282 |
| authorships[4].author.orcid | https://orcid.org/0009-0000-8786-1935 |
| authorships[4].author.display_name | Mayara da Costa Rodrigues |
| authorships[4].countries | BR |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I170935008 |
| authorships[4].affiliations[0].raw_affiliation_string | Pontifícia Universidade Católica de Minas Gerais |
| authorships[4].institutions[0].id | https://openalex.org/I170935008 |
| authorships[4].institutions[0].ror | https://ror.org/03j1rr444 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I170935008 |
| authorships[4].institutions[0].country_code | BR |
| authorships[4].institutions[0].display_name | Pontifícia Universidade Católica de Minas Gerais |
| authorships[4].author_position | last |
| authorships[4].raw_author_name | Mário Jorge Rios Gil Rodrigues |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Pontifícia Universidade Católica de Minas Gerais |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://periodicorease.pro.br/rease/article/download/17416/9780 |
| open_access.oa_status | diamond |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | COMPLICAÇÕES DA NEURITE ÓPTICA EM PACIENTES IMUNOSSUPRIMIDOS |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T06:51:31.235846 |
| primary_topic.id | https://openalex.org/T12599 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9710999727249146 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2731 |
| primary_topic.subfield.display_name | Ophthalmology |
| primary_topic.display_name | Retinal and Optic Conditions |
| related_works | https://openalex.org/W2899084033, https://openalex.org/W2748952813, https://openalex.org/W3031052312, https://openalex.org/W4389568370, https://openalex.org/W3032375762, https://openalex.org/W1995515455, https://openalex.org/W2080531066, https://openalex.org/W3108674512, https://openalex.org/W1506200166, https://openalex.org/W1489783725 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.51891/rease.v10i12.17416 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210238184 |
| best_oa_location.source.issn | 2675-3375 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2675-3375 |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Revista Ibero-Americana de Humanidades, Ciências e Educação |
| best_oa_location.source.host_organization | https://openalex.org/P4365394759 |
| best_oa_location.source.host_organization_name | Arche Scientific and Editorial Consultancy |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4365394759 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://periodicorease.pro.br/rease/article/download/17416/9780 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Revista Ibero-Americana de Humanidades, Ciências e Educação |
| best_oa_location.landing_page_url | https://doi.org/10.51891/rease.v10i12.17416 |
| primary_location.id | doi:10.51891/rease.v10i12.17416 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210238184 |
| primary_location.source.issn | 2675-3375 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2675-3375 |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Revista Ibero-Americana de Humanidades, Ciências e Educação |
| primary_location.source.host_organization | https://openalex.org/P4365394759 |
| primary_location.source.host_organization_name | Arche Scientific and Editorial Consultancy |
| primary_location.source.host_organization_lineage | https://openalex.org/P4365394759 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://periodicorease.pro.br/rease/article/download/17416/9780 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Revista Ibero-Americana de Humanidades, Ciências e Educação |
| primary_location.landing_page_url | https://doi.org/10.51891/rease.v10i12.17416 |
| publication_date | 2024-12-05 |
| publication_year | 2024 |
| referenced_works_count | 0 |
| abstract_inverted_index.A | 1, 51, 97, 134, 316 |
| abstract_inverted_index.O | 296 |
| abstract_inverted_index.a | 20, 24, 55, 192, 210, 242, 279, 285, 331 |
| abstract_inverted_index.e | 47, 63, 86, 92, 117, 131, 154, 164, 184, 248, 270, 300, 310 |
| abstract_inverted_index.o | 61, 83, 90, 249, 256, 261, 290, 293, 301 |
| abstract_inverted_index.10 | 145, 178 |
| abstract_inverted_index.Em | 27, 276 |
| abstract_inverted_index.Os | 206 |
| abstract_inverted_index.ao | 31, 234, 273, 336 |
| abstract_inverted_index.as | 38, 69, 87 |
| abstract_inverted_index.da | 40, 71, 169, 224, 252, 266, 268, 271, 298 |
| abstract_inverted_index.de | 15, 33, 49, 113, 158, 198, 219, 226, 229, 236, 244 |
| abstract_inverted_index.do | 7, 58, 105 |
| abstract_inverted_index.em | 13, 74, 140, 149, 172, 182, 213 |
| abstract_inverted_index.no | 231 |
| abstract_inverted_index.of | 119 |
| abstract_inverted_index.os | 122 |
| abstract_inverted_index.ou | 35, 195 |
| abstract_inverted_index.se | 138 |
| abstract_inverted_index.um | 245, 312 |
| abstract_inverted_index.à | 202 |
| abstract_inverted_index.é | 4, 263 |
| abstract_inverted_index.Web | 118 |
| abstract_inverted_index.com | 101, 147, 180, 330 |
| abstract_inverted_index.dos | 136, 333 |
| abstract_inverted_index.foi | 99 |
| abstract_inverted_index.nas | 103, 111 |
| abstract_inverted_index.nos | 78, 143, 176 |
| abstract_inverted_index.que | 10, 80, 189, 196, 209, 287, 319 |
| abstract_inverted_index.ser | 44, 325 |
| abstract_inverted_index.uma | 5 |
| abstract_inverted_index.uso | 32, 235 |
| abstract_inverted_index.base | 102 |
| abstract_inverted_index.como | 23, 221 |
| abstract_inverted_index.foco | 148, 181 |
| abstract_inverted_index.mais | 45, 65, 322 |
| abstract_inverted_index.não | 190, 200 |
| abstract_inverted_index.para | 89, 254, 306 |
| abstract_inverted_index.pode | 11, 53 |
| abstract_inverted_index.são | 304 |
| abstract_inverted_index.Além | 259 |
| abstract_inverted_index.Foram | 108, 160, 186 |
| abstract_inverted_index.além | 228 |
| abstract_inverted_index.anos, | 146, 179 |
| abstract_inverted_index.bases | 112 |
| abstract_inverted_index.dados | 114 |
| abstract_inverted_index.está | 282 |
| abstract_inverted_index.maior | 217 |
| abstract_inverted_index.nervo | 8 |
| abstract_inverted_index.perda | 14, 225 |
| abstract_inverted_index.podem | 43, 81, 324 |
| abstract_inverted_index.risco | 218 |
| abstract_inverted_index.sendo | 17 |
| abstract_inverted_index.sobre | 167 |
| abstract_inverted_index.tanto | 289 |
| abstract_inverted_index."perda | 132 |
| abstract_inverted_index.Muitos | 239 |
| abstract_inverted_index.Scielo | 116 |
| abstract_inverted_index.buscas | 110 |
| abstract_inverted_index.casos, | 328 |
| abstract_inverted_index.desses | 94 |
| abstract_inverted_index.devido | 30, 233 |
| abstract_inverted_index.disso, | 260 |
| abstract_inverted_index.estado | 337 |
| abstract_inverted_index.evitar | 307 |
| abstract_inverted_index.melhor | 313 |
| abstract_inverted_index.nesses | 327 |
| abstract_inverted_index.quadro | 84 |
| abstract_inverted_index.quanto | 292 |
| abstract_inverted_index.riscos | 334 |
| abstract_inverted_index.sempre | 329 |
| abstract_inverted_index.sugere | 318 |
| abstract_inverted_index.PRISMA. | 107 |
| abstract_inverted_index.PubMed, | 115 |
| abstract_inverted_index.agravar | 82 |
| abstract_inverted_index.alterar | 54 |
| abstract_inverted_index.artigos | 137 |
| abstract_inverted_index.estudos | 141, 152, 162, 188, 240 |
| abstract_inverted_index.fatores | 79 |
| abstract_inverted_index.focando | 77 |
| abstract_inverted_index.impacto | 257 |
| abstract_inverted_index.neurite | 2, 41, 72, 170, 203, 211, 280 |
| abstract_inverted_index.precoce | 247 |
| abstract_inverted_index.tratar. | 50 |
| abstract_inverted_index.visual. | 258, 315 |
| abstract_inverted_index.visão, | 16, 227 |
| abstract_inverted_index.óptica | 3, 42, 73, 171, 212, 281 |
| abstract_inverted_index.óptico | 9 |
| abstract_inverted_index."neurite | 125 |
| abstract_inverted_index.Analisar | 68 |
| abstract_inverted_index.Science, | 120 |
| abstract_inverted_index.clínico | 85 |
| abstract_inverted_index.controle | 250, 297 |
| abstract_inverted_index.doenças | 21, 36, 199 |
| abstract_inverted_index.intensas | 46 |
| abstract_inverted_index.promover | 311 |
| abstract_inverted_index.resposta | 56, 272 |
| abstract_inverted_index.resultar | 12 |
| abstract_inverted_index.revisão | 98 |
| abstract_inverted_index.rigoroso | 251 |
| abstract_inverted_index.sequelas | 308 |
| abstract_inverted_index.tornando | 60 |
| abstract_inverted_index.tratavam | 197 |
| abstract_inverted_index.visual". | 133 |
| abstract_inverted_index.óptica. | 204 |
| abstract_inverted_index.últimos | 144, 177 |
| abstract_inverted_index.Objetivo: | 67 |
| abstract_inverted_index.abordavam | 191 |
| abstract_inverted_index.acelerada | 223 |
| abstract_inverted_index.adequado. | 295 |
| abstract_inverted_index.apresenta | 216 |
| abstract_inverted_index.associada | 19, 284 |
| abstract_inverted_index.checklist | 106 |
| abstract_inverted_index.clínicos | 153, 163 |
| abstract_inverted_index.difíceis | 48 |
| abstract_inverted_index.esclerose | 25 |
| abstract_inverted_index.gravidade | 267 |
| abstract_inverted_index.indicaram | 208 |
| abstract_inverted_index.inerentes | 335 |
| abstract_inverted_index.minimizar | 255 |
| abstract_inverted_index.pacientes | 28, 75, 173, 214, 277 |
| abstract_inverted_index.pesquisas | 155 |
| abstract_inverted_index.realizada | 100 |
| abstract_inverted_index.revisões | 150, 165 |
| abstract_inverted_index.seguintes | 123 |
| abstract_inverted_index.seleção | 135 |
| abstract_inverted_index.óptica", | 126 |
| abstract_inverted_index."pacientes | 127 |
| abstract_inverted_index.Inclusão: | 159 |
| abstract_inverted_index.abordagens | 320 |
| abstract_inverted_index.agressivas | 323 |
| abstract_inverted_index.concentrou | 139 |
| abstract_inverted_index.dependendo | 265 |
| abstract_inverted_index.destacaram | 241 |
| abstract_inverted_index.dificultam | 288 |
| abstract_inverted_index.diretrizes | 104 |
| abstract_inverted_index.essenciais | 305 |
| abstract_inverted_index.excluídos | 187 |
| abstract_inverted_index.incluídos | 161 |
| abstract_inverted_index.literatura | 317 |
| abstract_inverted_index.múltipla. | 26 |
| abstract_inverted_index.organismo, | 59 |
| abstract_inverted_index.pacientes. | 95 |
| abstract_inverted_index.publicados | 142, 175 |
| abstract_inverted_index.realizadas | 109 |
| abstract_inverted_index.resultados | 207 |
| abstract_inverted_index.tratamento | 64, 91, 232, 294 |
| abstract_inverted_index.utilizando | 121 |
| abstract_inverted_index.variável, | 264 |
| abstract_inverted_index.Conclusão: | 275 |
| abstract_inverted_index.Resultados: | 205 |
| abstract_inverted_index.autoimunes, | 22 |
| abstract_inverted_index.permanentes | 309 |
| abstract_inverted_index.população | 193 |
| abstract_inverted_index.progressão | 222 |
| abstract_inverted_index.tratamento. | 185, 274 |
| abstract_inverted_index.Metodologia: | 96 |
| abstract_inverted_index.descritores: | 124 |
| abstract_inverted_index.diagnóstico | 62, 183, 246, 291 |
| abstract_inverted_index.dificuldades | 230 |
| abstract_inverted_index.importância | 243 |
| abstract_inverted_index.inflamação | 6, 269 |
| abstract_inverted_index.medicamentos | 34, 237 |
| abstract_inverted_index.necessárias | 326 |
| abstract_inverted_index.prognóstico | 93, 262, 314 |
| abstract_inverted_index.relacionadas | 201 |
| abstract_inverted_index.subjacentes, | 37 |
| abstract_inverted_index."tratamento", | 129 |
| abstract_inverted_index.Introdução: | 0 |
| abstract_inverted_index.desafiadores. | 66 |
| abstract_inverted_index.especializado | 303 |
| abstract_inverted_index.experimentais | 156 |
| abstract_inverted_index.implicações | 88 |
| abstract_inverted_index.inflamatória | 57 |
| abstract_inverted_index.sistemáticas | 166 |
| abstract_inverted_index.terapêuticas | 321 |
| abstract_inverted_index.acompanhamento | 302 |
| abstract_inverted_index.complicações | 39, 70, 168, 286 |
| abstract_inverted_index.consideração | 332 |
| abstract_inverted_index.frequentemente | 18, 283 |
| abstract_inverted_index.sistemáticas, | 151 |
| abstract_inverted_index.complicações, | 220 |
| abstract_inverted_index.imunossuprimida | 194 |
| abstract_inverted_index."complicações" | 130 |
| abstract_inverted_index.imunossupressão | 52, 253, 299 |
| abstract_inverted_index.imunossuprimido. | 338 |
| abstract_inverted_index.imunossuprimidos | 215 |
| abstract_inverted_index.imunossuprimidos, | 29, 76, 174, 278 |
| abstract_inverted_index.imunossupressores. | 238 |
| abstract_inverted_index.imunossuprimidos", | 128 |
| abstract_inverted_index.relevantes.Critérios | 157 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 5 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.6700000166893005 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.41325387 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |